Effect of simultaneous expression of various usoforms of vascular endothelial growth factor VEGF and fibroblast growth factor FGF2 on proliferation of human umbilical cord blood cells HUVEC
- Authors: Salafutdinov II1, Shafigullina AK1, Yalvach ME1, Kudryashova NV1, Lagar'kova MA1, Shutova MV1, Kiselev SP1, Masgutov RF1, Zhdanov RI1, Kiyasov AL1, Islamov PP1, Rizvanov AA1, Salafutdinov II2, Shafigullina AK3, Yalvac ME4, Kudryashova NV2, Lagarkova MA5, Shutova MV5, Kiselev SL6, Masgutov RE7, Zhdanov RI8, Kiyasov АР3, Islamov RR3, Rizvanov AA9
-
Affiliations:
- Kazan Federal University, Kazan
- Kazan State Medical University, Kazan
- Yeditepe University, Istanbul, Turkey
- Vavilov Institute of General Genetics RAS, Moscow«LKT» Ltd., Moscow
- Vavilov Institute of General Genetics RAS, Moscow
- Kazan Federal University, KazanKazan State Medical University, Kazan
- Kazan Federal University, KazanYeditepe University, Istanbul, TurkeyInstitute of general pathology and pathophysiology RAMS, Moscow
- Kazan Federal University, KazanKazan State Medical University, KazanYeditepe University, Istanbul, Turkey
- Issue: Vol 5, No 2 (2010)
- Pages: 62-67
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/121479
- DOI: https://doi.org/10.23868/gc121479
- ID: 121479
Cite item
Abstract
About the authors
I I Salafutdinov
A K Shafigullina
M E Yalvach
N V Kudryashova
M A Lagar'kova
M V Shutova
S P Kiselev
R F Masgutov
R I Zhdanov
A L Kiyasov
P P Islamov
A A Rizvanov
I I Salafutdinov
Kazan Federal University, KazanKazan Federal University, Kazan
A K Shafigullina
Kazan State Medical University, KazanKazan State Medical University, Kazan
M E Yalvac
Yeditepe University, Istanbul, TurkeyYeditepe University, Istanbul, Turkey
N V Kudryashova
Kazan Federal University, KazanKazan Federal University, Kazan
M A Lagarkova
Vavilov Institute of General Genetics RAS, Moscow«LKT» Ltd., MoscowVavilov Institute of General Genetics RAS, Moscow«LKT» Ltd., Moscow
M V Shutova
Vavilov Institute of General Genetics RAS, Moscow«LKT» Ltd., MoscowVavilov Institute of General Genetics RAS, Moscow«LKT» Ltd., Moscow
S L Kiselev
Vavilov Institute of General Genetics RAS, MoscowVavilov Institute of General Genetics RAS, Moscow
R E Masgutov
Kazan Federal University, KazanKazan State Medical University, KazanKazan Federal University, KazanKazan State Medical University, Kazan
R I Zhdanov
Kazan Federal University, KazanYeditepe University, Istanbul, TurkeyInstitute of general pathology and pathophysiology RAMS, MoscowKazan Federal University, KazanYeditepe University, Istanbul, TurkeyInstitute of general pathology and pathophysiology RAMS, Moscow
А Р Kiyasov
Kazan State Medical University, KazanKazan State Medical University, Kazan
R R Islamov
Kazan State Medical University, KazanKazan State Medical University, Kazan
A A Rizvanov
Kazan Federal University, KazanKazan State Medical University, KazanYeditepe University, Istanbul, TurkeyKazan Federal University, KazanKazan State Medical University, KazanYeditepe University, Istanbul, Turkey
References
- Folkman J. Tumour angiogenesis: therapeutic implications. N. Engl. J. Med. 1971; 285: 1182-6.
- Gradin K., McGuire J., Wenger R.H. et al. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the ARNT transcription factor. Mol. Cell. Biol. 1996; 16: 5221-31.
- Huang L.E., Arany Z., Livingston D.M. et al. Activation of hypoxia-nducible transcription factor depends primarily upon redox-sensitive stabilization of its -subunit. J. Biol. Chem. 1996; 271: 32253-59.
- Kuwabara K., Ogawa S., Matsumoto M. Hypoxia mediated induction of acidic basic fibroblast growth factor and platlet-derived growth factor in mono nuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc. Nat. Acad. Sci. USA 1995; 92: 4606-10.
- Forsythe J.A., Jiang B.H., Iyer N.V. et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biology. 1996; 16: 4604-13.
- Dvorak H.F., Dvorak A.M., Manseau E.J. et al. Fibrin gel investment associated with line 1 and 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J. Natl. Cancer Inst. 1979; 62: 1459-72.
- Ferrara N., Houck K., Jakeman L. et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 1992; 13: 18-32.
- Ferrara N., Gerber H.P, LeCouter J. The biology of VEGF and its receptors. Nature Medicine 2003; 6: 669-76.
- Robinson J.С The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. of Cell Science 2001; 5: 853-65.
- Yamazaki Y. Molecular and functional diversity of vascular endothelial growth factors. Mol. Div. 2006; 10: 515-27.
- Yoo P.S. Post-transcriptional regulation of vascular endothelial growth factor: Implications for tumor angiogenesis. World J. Gastroenterol. 2006; 12: 4937-42.
- Bogaert E. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases. Muscle S. Nerve 2006; 34: 391-405.
- Whittle С Heterogeneous vascular endothelial growth factor [VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Clinical Science 1999; 97: 303-12.
- Armelin H.A. Pituitary Extracts and Steroid Hormones in the Control of 3T3 Cell Growth. PNAS 1973; 70: 2702-6.
- Ornitz, D. M. and Itoh, N. Fibroblast growth factors. Genome Biology 2001; 2(3): 3001-12.
- Schweigerer L, Neufeld G., Friedman J. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987; 325: 257-259.
- Van den Berghe L, Laurell H., Isabelle H. et al. FIF [Fibroblast Growth Factor-2 (FGF-2)-lnteracting-Factor], a Nuclear Putatively Antiapoptotic Factor, interacts specifically with FGF. Mol. Endocrinol. 2000; 14 (11): 1709-24.
- Bugler В., Amalric F., Prats H. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol. Cell. Biol. 1991; 11: 573-7.
- Парфенова E.B., Ткачук В.А. Перспективы генной терапии сердечно-сосудистых заболеваний. Вопр. мед. хим. 2000; 46: 293-310.
- Sabti Н. Therapeutic angiogenesis in cardiovascular disease. J. of Cardiothoracic Surg. 2007; 2: 49-56.
- Kano M.R., Morishita Y., Iwata С et al. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B- PDGFR beta signaling. J. Cell Sci. 2005; 118: 3759-68.
- Ley C, Olsen M., Lund E. et al. Angiogenic synergy of bFGF and VEGF is antagonized by angiopoietin-2 in a modified in vivo Matrigel assay. Microvasc. Res. 2004; 68: 161-8.
- Pepper M.S., Ferrarab N., Orcib L. et al. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 1992; 189(2): 824-31.
- Ikeda Y., Fukuda N., Wada M. et al. Development of Angiogenic Cell and Gene Therapy by Transplantation of Umbilical Cord Blood with Vascular Endothelial Growth Factor Gene. Hypertens. Res. 2004; 27(2): 119-128.
- Chen H.K., Hung H.F., Shyu K.G. et al. Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction. Eur. J. Clin. Invest. 2005; 35: 677-86.
- Lu F., Li J., Gao J. et al. Improvement of the Survival of Human Autologous Fat Transplantation by Using VEGF-Transfected Adipose-Derived Stem Cells Plastic and Reconstructive Surgery 2009; 124(5): 1437-46.
- <http://www.ncbi.nlm.nih.gov/Genbank>
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227(5259): 680-5.
- Onda Т., Honmou 0., Harada K. et al. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia J. Cereb. Blood Flow Metab. 2008; 28(2): 329-40.
- Rizvanov A.A., Kiyasov A.P., Gaziziov I.M., et al. Human umbilical cord blood cells transfected with VEGF, L1CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neurotrophic factors to support neuro-genesis - a novel approach in stem cell therapy. Neurochemistry International. 2008; 53: 389-94.
- Smadja D.M., Cornet A., Emmerich J. et al. Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy. Cell Biol. Toxicol. 2007; 23(4): 223-39.
- Chen X., Li Y., Wang L. et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002; 22: 275-9.
- Rophael J.A., Craf R.O., Palmer J.A. et al. Angiogenic Growth Factor Synergism in a Murine Tissue Engineering Model of Angiogenesis and Adipogenes. Am. J. Pathol. 2007; 171(6): 2048-57.